These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34219712)

  • 1. Neuronal Cell Cycle Re-Entry Enhances Neuropathological Features in AppNLF Knock-In Mice.
    Barrett T; Stangis KA; Saito T; Saido T; Park KHJ
    J Alzheimers Dis; 2021; 82(4):1683-1702. PubMed ID: 34219712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gliosis Precedes Amyloid-β Deposition and Pathological Tau Accumulation in the Neuronal Cell Cycle Re-Entry Mouse Model of Alzheimer's Disease.
    Park KHJ; Barrett T
    J Alzheimers Dis Rep; 2020 Jul; 4(1):243-253. PubMed ID: 32904753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology.
    Lopes JP; Blurton-Jones M; Yamasaki TR; Agostinho P; LaFerla FM
    J Alzheimers Dis; 2009; 16(3):541-9. PubMed ID: 19276549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.
    Kuwar R; Rolfe A; Di L; Blevins H; Xu Y; Sun X; Bloom GS; Zhang S; Sun D
    J Alzheimers Dis; 2021; 82(4):1769-1783. PubMed ID: 34219728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abeta oligomers induce neuronal cell cycle events in Alzheimer's disease.
    Varvel NH; Bhaskar K; Patil AR; Pimplikar SW; Herrup K; Lamb BT
    J Neurosci; 2008 Oct; 28(43):10786-93. PubMed ID: 18945886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle re-entry in Alzheimer's disease: a major neuropathological characteristic?
    Lopes JP; Oliveira CR; Agostinho P
    Curr Alzheimer Res; 2009 Jun; 6(3):205-12. PubMed ID: 19519302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct chronology of neuronal cell cycle re-entry and tau pathology in the 3xTg-AD mouse model and Alzheimer's disease patients.
    Hradek AC; Lee HP; Siedlak SL; Torres SL; Jung W; Han AH; Lee HG
    J Alzheimers Dis; 2015; 43(1):57-65. PubMed ID: 25061053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's disease neuropathology.
    Xiang Z; Ho L; Valdellon J; Borchelt D; Kelley K; Spielman L; Aisen PS; Pasinetti GM
    Neurobiol Aging; 2002; 23(3):327-34. PubMed ID: 11959394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease.
    Lee HG; Casadesus G; Zhu X; Castellani RJ; McShea A; Perry G; Petersen RB; Bajic V; Smith MA
    Neurochem Int; 2009 Feb; 54(2):84-8. PubMed ID: 19114068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-β signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer's disease.
    Seward ME; Swanson E; Norambuena A; Reimann A; Cochran JN; Li R; Roberson ED; Bloom GS
    J Cell Sci; 2013 Mar; 126(Pt 5):1278-86. PubMed ID: 23345405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP/Ld transgenic mouse model of Alzheimer's disease.
    Kukreja L; Kujoth GC; Prolla TA; Van Leuven F; Vassar R
    Mol Neurodegener; 2014 May; 9():16. PubMed ID: 24885175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance.
    Gontier G; George C; Chaker Z; Holzenberger M; Aïd S
    J Neurosci; 2015 Aug; 35(33):11500-13. PubMed ID: 26290229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.
    Kodis EJ; Choi S; Swanson E; Ferreira G; Bloom GS
    Alzheimers Dement; 2018 Oct; 14(10):1302-1312. PubMed ID: 30293574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.
    Kocherhans S; Madhusudan A; Doehner J; Breu KS; Nitsch RM; Fritschy JM; Knuesel I
    J Neurosci; 2010 Jul; 30(27):9228-40. PubMed ID: 20610758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in Tau Pathology in P290S
    Huang M; Macdonald J; Lavenir I; Chen R; Craxton M; Slavik-Smith E; Davies SW; Goedert M
    eNeuro; 2022; 9(6):. PubMed ID: 36635241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow.
    Li H; Guo Q; Inoue T; Polito VA; Tabuchi K; Hammer RE; Pautler RG; Taffet GE; Zheng H
    Mol Neurodegener; 2014 Aug; 9():28. PubMed ID: 25108425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.